William Blair Issues Optimistic Outlook for SLP Earnings

Simulations Plus, Inc. (NASDAQ:SLP) – Equities research analysts at William Blair lifted their Q3 2025 earnings per share (EPS) estimates for shares of Simulations Plus in a report issued on Wednesday, January 8th. William Blair analyst M. Smock now forecasts that the technology company will post earnings per share of $0.34 for the quarter, up from their prior forecast of $0.32. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Simulations Plus’ current full-year earnings is $1.10 per share. William Blair also issued estimates for Simulations Plus’ Q3 2026 earnings at $0.44 EPS.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. The firm had revenue of $18.70 million for the quarter, compared to analysts’ expectations of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company’s quarterly revenue was up 19.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.18 EPS.

SLP has been the subject of several other research reports. Stephens initiated coverage on Simulations Plus in a research report on Friday, November 15th. They issued an “overweight” rating and a $39.00 price target for the company. StockNews.com cut shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. KeyCorp dropped their target price on shares of Simulations Plus from $40.00 to $35.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, BTIG Research reduced their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Simulations Plus currently has a consensus rating of “Moderate Buy” and a consensus price target of $49.00.

Simulations Plus Trading Down 7.2 %

Shares of NASDAQ:SLP opened at $28.21 on Thursday. The stock has a fifty day simple moving average of $29.81 and a two-hundred day simple moving average of $33.96. Simulations Plus has a 12-month low of $24.00 and a 12-month high of $51.22. The stock has a market capitalization of $566.60 million, a price-to-earnings ratio of 57.57 and a beta of 0.80.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $31.76, for a total value of $635,200.00. Following the transaction, the director now directly owns 3,442,584 shares in the company, valued at approximately $109,336,467.84. This trade represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 19.40% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Simulations Plus

Several hedge funds and other institutional investors have recently modified their holdings of SLP. Tributary Capital Management LLC lifted its stake in shares of Simulations Plus by 54.7% during the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock valued at $10,425,000 after buying an additional 115,122 shares in the last quarter. Royce & Associates LP lifted its position in shares of Simulations Plus by 28.8% in the third quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after acquiring an additional 53,092 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Simulations Plus by 10.1% in the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after acquiring an additional 37,992 shares during the period. Congress Asset Management Co. grew its position in shares of Simulations Plus by 22.5% during the third quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock worth $6,613,000 after purchasing an additional 37,914 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its position in shares of Simulations Plus by 402.9% during the third quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company’s stock worth $1,279,000 after purchasing an additional 32,002 shares in the last quarter. 78.08% of the stock is currently owned by hedge funds and other institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.